|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
8
|
|
pubmed:dateCreated |
1994-8-24
|
|
pubmed:abstractText |
We examined the effect of high-dose selegiline in 16 treatment-resistant older depressive patients. We hypothesized that selegiline, at a dosage of 60 mg/d, would be at least partially effective but that the higher doses would not maintain the monoamine oxidase B selectivity observed with the lower doses of selegiline.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0003-990X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
51
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
607-15
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:7519005-Age Factors,
pubmed-meshheading:7519005-Aged,
pubmed-meshheading:7519005-Blood Pressure,
pubmed-meshheading:7519005-Depressive Disorder,
pubmed-meshheading:7519005-Dose-Response Relationship, Drug,
pubmed-meshheading:7519005-Double-Blind Method,
pubmed-meshheading:7519005-Drug Administration Schedule,
pubmed-meshheading:7519005-Female,
pubmed-meshheading:7519005-Humans,
pubmed-meshheading:7519005-Hydroxyindoleacetic Acid,
pubmed-meshheading:7519005-Hypotension, Orthostatic,
pubmed-meshheading:7519005-Male,
pubmed-meshheading:7519005-Methoxyhydroxyphenylglycol,
pubmed-meshheading:7519005-Middle Aged,
pubmed-meshheading:7519005-Placebos,
pubmed-meshheading:7519005-Psychiatric Status Rating Scales,
pubmed-meshheading:7519005-Selegiline,
pubmed-meshheading:7519005-Treatment Outcome
|
|
pubmed:year |
1994
|
|
pubmed:articleTitle |
High-dose selegiline in treatment-resistant older depressive patients.
|
|
pubmed:affiliation |
Section on Geriatric Psychiatry, National Institute of Mental Health, Bethesda, Md.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial
|
